• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血压正常性青光眼随访中偶然发现脉络膜新生血管膜:一例教学病例报告

Normotensive Glaucoma Follow-Up with Incidental Finding of Choroidal Neovascular Membrane: a Teaching Case Report.

作者信息

Bulson Ryan, Faridi Ambar

机构信息

Pacific University College of Optometry.

VA Portland Health Care System and at Oregon Health & Science University's Casey Eye Institute.

出版信息

Optom Educ. 2017 Summer;42(17):16-22.

PMID:37287474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10246759/
Abstract

Behind cataracts, glaucoma is the second leading cause of blindness worldwide. Patients with glaucoma are followed at regular intervals for testing to confirm stability of the disease; however, providers may need to divert from planned glaucoma testing when clinical findings suggest progression of comorbid ophthalmic conditions. This case report describes a patient presenting for a routine glaucoma follow-up appointment who was subsequently diagnosed with an acute choroidal neovascular membrane due to conversion from non-neovascular to neovascular age-related macular degeneration. The case highlights the management of normotensive glaucoma and both non-neovascular and neovascular macular degeneration.

摘要

在白内障之后,青光眼是全球第二大致盲原因。青光眼患者需定期接受检查以确认病情稳定;然而,当临床检查结果提示合并的眼科疾病进展时,医护人员可能需要偏离计划好的青光眼检查。本病例报告描述了一名前来进行常规青光眼随访预约的患者,该患者随后被诊断为急性脉络膜新生血管膜,原因是其年龄相关性黄斑变性从非新生血管性转变为新生血管性。该病例突出了正常眼压性青光眼以及非新生血管性和新生血管性黄斑变性的治疗。

相似文献

1
Normotensive Glaucoma Follow-Up with Incidental Finding of Choroidal Neovascular Membrane: a Teaching Case Report.血压正常性青光眼随访中偶然发现脉络膜新生血管膜:一例教学病例报告
Optom Educ. 2017 Summer;42(17):16-22.
2
Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study.老年人群中未受影响的第二眼新生血管性黄斑变性的早期无创性检测:EDNA 诊断准确性研究。
Health Technol Assess. 2022 Jan;26(8):1-142. doi: 10.3310/VLFL1739.
3
Using optical coherence tomography angiography in assessment of the anti-vascular endothelial growth factor effect for pathological vascular tissue in age-related macular degeneration and polypoidal choroidal vasculopathy.应用光相干断层扫描血管造影评估抗血管内皮生长因子治疗年龄相关性黄斑变性和息肉状脉络膜血管病变病理性血管组织的效果。
Eur J Ophthalmol. 2021 May;31(3):1267-1280. doi: 10.1177/1120672120913012. Epub 2020 Mar 31.
4
Optical Coherence Tomography-Angiography of Different Choroidal Neovascularization Subtypes in Wet Age-related Macular Degeneration.湿性年龄相关性黄斑变性不同脉络膜新生血管亚型的光学相干断层扫描血管造影
Folia Med (Plovdiv). 2019 Jun 1;61(2):317-326. doi: 10.2478/folmed-2018-0061.
5
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY REVEALS BLOOD FLOW IN CHOROIDAL NEOVASCULAR MEMBRANE IN REMISSION PHASE OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.光学相干断层扫描血管造影显示新生血管性年龄相关性黄斑变性缓解期脉络膜新生血管膜中的血流情况。
Retina. 2017 Apr;37(4):724-730. doi: 10.1097/IAE.0000000000001576.
6
Swept-source optical coherence tomography angiography features of sub-retinal fibrosis in neovascular age-related macular degeneration.扫频源光相干断层扫描血管造影在新生血管性年龄相关性黄斑变性中视网膜下纤维化的特征。
Clin Exp Ophthalmol. 2019 Mar;47(2):233-239. doi: 10.1111/ceo.13367. Epub 2018 Nov 13.
7
Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration treated with ranibizumab.经 ranibizumab 治疗的新生血管性年龄相关性黄斑变性的微视野测量视网膜功能变化。
Am J Ophthalmol. 2013 Jan;155(1):118-126.e1. doi: 10.1016/j.ajo.2012.07.009. Epub 2012 Sep 27.
8
Optical coherence tomography angiography markers associated with treatment response in neovascular age-related macular degeneration.光学相干断层扫描血管造影标志物与新生血管性年龄相关性黄斑变性的治疗反应相关。
Eur J Ophthalmol. 2021 May;31(3):1192-1200. doi: 10.1177/1120672120925790. Epub 2020 May 26.
9
Treatment of Co-existent occult choroidal neovascular membrane and macular hole.并存的隐匿性脉络膜新生血管膜和黄斑裂孔的治疗
Surv Ophthalmol. 2007 Sep-Oct;52(5):547-50. doi: 10.1016/j.survophthal.2007.06.005.
10
Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration.单侧新生血管性年龄相关性黄斑变性患者非新生血管对侧眼新生血管病变类型与临床特征的相关性
Retina. 2015 May;35(5):966-74. doi: 10.1097/IAE.0000000000000460.

本文引用的文献

1
Update on Normal Tension Glaucoma.正常眼压性青光眼的最新进展
J Ophthalmic Vis Res. 2016 Apr-Jun;11(2):204-8. doi: 10.4103/2008-322X.183914.
2
Optical Coherence Tomography Angiography in Retinal Diseases.视网膜疾病中的光学相干断层扫描血管造影术。
J Ophthalmic Vis Res. 2016 Jan-Mar;11(1):84-92. doi: 10.4103/2008-322X.180709.
3
Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials.抗血管内皮生长因子治疗新生血管性年龄相关性黄斑变性的五年结果:年龄相关性黄斑变性治疗试验比较
Ophthalmology. 2016 Aug;123(8):1751-1761. doi: 10.1016/j.ophtha.2016.03.045. Epub 2016 May 2.
4
Epidemiological and Clinical Baseline Characteristics as Predictive Biomarkers of Response to Anti-VEGF Treatment in Patients with Neovascular AMD.作为新生血管性年龄相关性黄斑变性患者抗VEGF治疗反应预测生物标志物的流行病学和临床基线特征
J Ophthalmol. 2016;2016:4367631. doi: 10.1155/2016/4367631. Epub 2016 Mar 17.
5
Platelet derived growth factor inhibitors: A potential therapeutic approach for ocular neovascularization.血小板衍生生长因子抑制剂:一种治疗眼部新生血管形成的潜在方法。
Saudi J Ophthalmol. 2015 Oct-Dec;29(4):287-91. doi: 10.1016/j.sjopt.2015.05.005. Epub 2015 Jun 6.
6
Age-Related Macular Degeneration: Advances in Management and Diagnosis.年龄相关性黄斑变性:管理与诊断的进展
J Clin Med. 2015 Feb 12;4(2):343-59. doi: 10.3390/jcm4020343.
7
Ganglion cell complex thickness in nonexudative age-related macular degeneration.非渗出性年龄相关性黄斑变性中神经节细胞复合体厚度
Eye (Lond). 2015 Aug;29(8):1076-80. doi: 10.1038/eye.2015.86. Epub 2015 May 29.
8
The current research status of normal tension glaucoma.正常眼压性青光眼的当前研究现状
Clin Interv Aging. 2014 Sep 16;9:1563-71. doi: 10.2147/CIA.S67263. eCollection 2014.
9
Twenty-four-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration.24 个月时 0.5mg 或 2.0mg 雷珠单抗治疗中心性浆液性脉络膜视网膜病变的疗效和安全性。
Ophthalmology. 2014 Nov;121(11):2181-92. doi: 10.1016/j.ophtha.2014.05.009. Epub 2014 Jul 9.
10
Reproducibility of macular ganglion cell-inner plexiform layer thickness measurement with cirrus HD-OCT in normal, hypertensive and glaucomatous eyes.正常眼、高血压眼和青光眼眼中 Cirrus HD-OCT 测量黄斑神经节细胞-内丛状层厚度的可重复性。
Br J Ophthalmol. 2014 Mar;98(3):322-8. doi: 10.1136/bjophthalmol-2012-302242. Epub 2013 Dec 4.